Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |